Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Total Liabilities (2018 - 2025)

Outset Medical (OM) has disclosed Total Liabilities for 8 consecutive years, with $137.5 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities fell 44.76% to $137.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $137.5 million through Dec 2025, down 44.76% year-over-year, with the annual reading at $137.5 million for FY2025, 44.76% down from the prior year.
  • Total Liabilities for Q4 2025 was $137.5 million at Outset Medical, up from $134.9 million in the prior quarter.
  • The five-year high for Total Liabilities was $253.0 million in Q1 2024, with the low at $73.2 million in Q1 2021.
  • Average Total Liabilities over 5 years is $145.4 million, with a median of $136.2 million recorded in 2025.
  • The sharpest move saw Total Liabilities plummeted 77.95% in 2021, then skyrocketed 79.51% in 2023.
  • Over 5 years, Total Liabilities stood at $89.4 million in 2021, then surged by 72.43% to $154.1 million in 2022, then grew by 23.87% to $190.9 million in 2023, then surged by 30.41% to $249.0 million in 2024, then plummeted by 44.76% to $137.5 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $137.5 million, $134.9 million, and $134.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.